APLS vs TT · rev $781.4M vs P/E 36, rev $11.32B
Apellis Pharmaceuticals Inc (APLS) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
APLS currently screens at market cap $2.29B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the APLS and TT stock pages for the full models.
Not investment advice.